206 related articles for article (PubMed ID: 35867890)
1. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
ElGendy K; Barwick TD; Auner HW; Chaidos A; Wallitt K; Sergot A; Rockall A
Br J Radiol; 2022 Sep; 95(1138):20220418. PubMed ID: 35867890
[TBL] [Abstract][Full Text] [Related]
2. Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging.
Barwick T; Orton M; Koh DM; Kaiser M; Rockall A; Tunariu N; Blackledge M; Messiou C
Br J Radiol; 2021 Apr; 94(1120):20200682. PubMed ID: 33733812
[TBL] [Abstract][Full Text] [Related]
3. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements.
Priola AM; Priola SM; Gned D; Giraudo MT; Brundu M; Righi L; Veltri A
J Magn Reson Imaging; 2017 Sep; 46(3):769-782. PubMed ID: 28117923
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.
De Paepe KN; Van Keerberghen CA; Agazzi GM; De Keyzer F; Gheysens O; Bechter O; Wolter P; Dierickx D; Janssens A; Verhoef G; Oyen R; Koole M; Vandecaveye V
Radiol Imaging Cancer; 2021 Mar; 3(2):e200061. PubMed ID: 33817648
[TBL] [Abstract][Full Text] [Related]
6. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
Boss MA; Snyder BS; Kim E; Flamini D; Englander S; Sundaram KM; Gumpeni N; Palmer SL; Choi H; Froemming AT; Persigehl T; Davenport MS; Malyarenko D; Chenevert TL; Rosen MA
J Magn Reson Imaging; 2022 Sep; 56(3):668-679. PubMed ID: 35143059
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer: Short-Term Reproducibility of Intravoxel Incoherent Motion Parameters and Apparent Diffusion Coefficient at 3T.
Jiang J; Yin J; Cui L; Gu X; Cai R; Gong S; Xu Y; Ma H; Mao J
J Magn Reson Imaging; 2018 Apr; 47(4):1003-1012. PubMed ID: 28741732
[TBL] [Abstract][Full Text] [Related]
8. Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility.
Yu H; Shen YQ; Tan FQ; Zhou ZL; Li Z; Hu DY; Morelli JN
World J Gastroenterol; 2019 Jul; 25(27):3619-3633. PubMed ID: 31367161
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-Weighted MRI in Patients with Testicular Tumors-Intra- and Interobserver Variability.
Pedersen MRV; Loft MK; Dam C; Rasmussen LÆL; Timm S
Curr Oncol; 2022 Feb; 29(2):837-847. PubMed ID: 35200570
[TBL] [Abstract][Full Text] [Related]
10. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
Giles SL; deSouza NM; Collins DJ; Morgan VA; West S; Davies FE; Morgan GJ; Messiou C
Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.
Weller A; Papoutsaki MV; Waterton JC; Chiti A; Stroobants S; Kuijer J; Blackledge M; Morgan V; deSouza NM
Eur Radiol; 2017 Nov; 27(11):4552-4562. PubMed ID: 28396997
[TBL] [Abstract][Full Text] [Related]
12. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
[TBL] [Abstract][Full Text] [Related]
13. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
[TBL] [Abstract][Full Text] [Related]
14. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
Latifoltojar A; Hall-Craggs M; Bainbridge A; Rabin N; Popat R; Rismani A; D'Sa S; Dikaios N; Sokolska M; Antonelli M; Ourselin S; Yong K; Taylor SA; Halligan S; Punwani S
Eur Radiol; 2017 Dec; 27(12):5325-5336. PubMed ID: 28656463
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement.
Bernardin L; Douglas NH; Collins DJ; Giles SL; O'Flynn EA; Orton M; deSouza NM
Eur Radiol; 2014 Feb; 24(2):502-11. PubMed ID: 24275802
[TBL] [Abstract][Full Text] [Related]
17. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
[TBL] [Abstract][Full Text] [Related]
18. Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.
Michoux NF; Ceranka JW; Vandemeulebroucke J; Peeters F; Lu P; Absil J; Triqueneaux P; Liu Y; Collette L; Willekens I; Brussaard C; Debeir O; Hahn S; Raeymaekers H; de Mey J; Metens T; Lecouvet FE
Eur Radiol; 2021 Jul; 31(7):4514-4527. PubMed ID: 33409773
[TBL] [Abstract][Full Text] [Related]
19. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma.
Giles SL; Messiou C; Collins DJ; Morgan VA; Simpkin CJ; West S; Davies FE; Morgan GJ; deSouza NM
Radiology; 2014 Jun; 271(3):785-94. PubMed ID: 24475858
[TBL] [Abstract][Full Text] [Related]
20. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
